203 related articles for article (PubMed ID: 8986010)
1. Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine.
von Moltke LL; Greenblatt DJ; Duan SX; Schmider J; Kudchadker L; Fogelman SM; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1996 Dec; 128(4):398-407. PubMed ID: 8986010
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Ball SE; Ahern D; Scatina J; Kao J
Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
[TBL] [Abstract][Full Text] [Related]
3. O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants.
Fogelman SM; Schmider J; Venkatakrishnan K; von Moltke LL; Harmatz JS; Shader RI; Greenblatt DJ
Neuropsychopharmacology; 1999 May; 20(5):480-90. PubMed ID: 10192828
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes.
Kobayashi K; Nakajima M; Oshima K; Shimada N; Yokoi T; Chiba K
Drug Metab Dispos; 1999 Aug; 27(8):860-5. PubMed ID: 10421611
[TBL] [Abstract][Full Text] [Related]
5. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
6. Fluvoxamine is a potent inhibitor of cytochrome P4501A2.
Brøsen K; Skjelbo E; Rasmussen BB; Poulsen HE; Loft S
Biochem Pharmacol; 1993 Mar; 45(6):1211-4. PubMed ID: 8466541
[TBL] [Abstract][Full Text] [Related]
7. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
Hesse LM; Venkatakrishnan K; Court MH; von Moltke LL; Duan SX; Shader RI; Greenblatt DJ
Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
[TBL] [Abstract][Full Text] [Related]
8. Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.
Jurima-Romet M; Wright M; Neigh S
Br J Clin Pharmacol; 1998 Mar; 45(3):318-21. PubMed ID: 10896409
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
von Moltke LL; Greenblatt DJ; Court MH; Duan SX; Harmatz JS; Shader RI
J Clin Psychopharmacol; 1995 Apr; 15(2):125-31. PubMed ID: 7782485
[TBL] [Abstract][Full Text] [Related]
10. Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes.
Nakajima M; Kobayashi K; Oshima K; Shimada N; Tokudome S; Chiba K; Yokoi T
Xenobiotica; 1999 Sep; 29(9):885-98. PubMed ID: 10548449
[TBL] [Abstract][Full Text] [Related]
11. Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions.
von Moltke LL; Greenblatt DJ; Granda BW; Grassi JM; Schmider J; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1999 Jul; 145(1):113-22. PubMed ID: 10445380
[TBL] [Abstract][Full Text] [Related]
12. Human cytochromes mediating N-demethylation of fluoxetine in vitro.
von Moltke LL; Greenblatt DJ; Duan SX; Schmider J; Wright CE; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1997 Aug; 132(4):402-7. PubMed ID: 9298519
[TBL] [Abstract][Full Text] [Related]
13. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
[TBL] [Abstract][Full Text] [Related]
14. N-demethylation of amitriptyline in vitro: role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors.
Schmider J; Greenblatt DJ; von Moltke LL; Harmatz JS; Shader RI
J Pharmacol Exp Ther; 1995 Nov; 275(2):592-7. PubMed ID: 7473143
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.
Yang TJ; Sai Y; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine.
Rasmussen BB; Maënpää J; Pelkonen O; Loft S; Poulsen HE; Lykkesfeldt J; Brøsen K
Br J Clin Pharmacol; 1995 Feb; 39(2):151-9. PubMed ID: 7742153
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
Bourrié M; Meunier V; Berger Y; Fabre G
J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
von Moltke LL; Greenblatt DJ; Cotreau-Bibbo MM; Duan SX; Harmatz JS; Shader RI
J Pharmacol Exp Ther; 1994 Mar; 268(3):1278-83. PubMed ID: 8138941
[TBL] [Abstract][Full Text] [Related]
19. Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
J Pharm Sci; 1998 Dec; 87(12):1502-7. PubMed ID: 10189256
[TBL] [Abstract][Full Text] [Related]
20. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A.
Haduch A; Wójcikowski J; Daniel WA
Eur Neuropsychopharmacol; 2006 Apr; 16(3):178-86. PubMed ID: 16246530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
